Skip to content
  • Sunday, 26 July 2026
  • 3:18 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Arc Mediates Intercellular Tau Transmission via Extracellular Vesicles and Represents a Potential Target for Slowing Alzheimer’s Progression
Neuroscience & Brain Research

Arc Mediates Intercellular Tau Transmission via Extracellular Vesicles and Represents a Potential Target for Slowing Alzheimer’s Progression

Rifan Muazin Jul 8, 2026 0

In a significant breakthrough for neurodegenerative research, scientists have identified a surprising biological mechanism that facilitates the spread of Alzheimer’s…

Read More
Laboratory Automation & Robotics

Pioneering Immune-Based Therapies: How NK Cell-Derived Extracellular Vesicles Offer New Hope for Traumatic Brain Injury and Alzheimer’s Disease

Lana Keisha Jul 3, 2026 0

Traumatic brain injury (TBI) stands as a formidable global health crisis, impacting an estimated 69 million individuals each year with…

Read More
Biotech & Genetic Research

Nature-Inspired Precision: International Study Unveils Targeted Gene Therapy Delivery Using Specific Extracellular Vesicles

Jia Lissa Apr 25, 2026 0

A groundbreaking international study, spearheaded by researchers from the University of Ottawa Faculty of Medicine in Canada, has introduced a…

Read More
PharmSci 360 2026 heads to New Orleans this OctoberLilly Ascends to Top Pharma Company by Revenue in FY2025, Fueled by Mounjaro and Zepbound’s Explosive GrowthTime-Series Feature Engineering with Python ItertoolsMachine Learning Reveals How High Pressure and Surface Chemistry Dictate Water Reactivity in Nanoconfined Environments
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ